Structural basis for the binding of high affinity phosphopeptides to Stat3

Area of Science:

• Oncology
• Molecular Biology
• Structural Biology

Background:

• Signal transducer and activator of transcription 3 (Stat3) is constitutively active in various cancers, promoting tumor growth.
• Stat3's SH2 domain binds phosphotyrosine residues, making it a target for cancer drug development.

Purpose of the Study:

• To elucidate the structural basis of phosphopeptide binding to the Stat3 SH2 domain.
• To identify key residues and interactions for designing Stat3 inhibitors.

Main Methods:

• Molecular modeling and docking of phosphopeptides to the Stat3 SH2 domain.
• Analysis of existing STAT protein crystal structures.
• Structure-affinity studies using modified peptides.

Main Results:

• A specific pocket in the Stat3 SH2 domain was identified, accommodating glutamine at position pY+3.
• Molecular modeling predicted tight binding of glutamine via hydrogen bonds.
• Experimental studies supported the predicted peptide-protein interactions.

Conclusions:

• The glutamine residue at pY+3 is a key specificity determinant for Stat3 SH2 domain binding.
• Understanding these interactions facilitates the design of targeted Stat3 peptidomimetic inhibitors for cancer therapy.